Medtronic Must Produce InFuse Docs In Securities Suit
After much back and forth, a Minnesota federal judge on Wednesday ordered Medtronic Inc. to turn over years of medical studies on the safety of the InFuse spinal graft as a...To view the full article, register now.
Already a subscriber? Click here to view full article